AeirBio Inc.
aribio.com

AeirBio, Inc., is a biotechnology company focused on developing novel therapies for the treatment of solid tumors, targeting the Ceramide/ENT1 pathway.  The Company is a spinout from Memorial Sloan Kettering Cancer Center in NYC. AeirBio’s compounds are designed to alter the tumor micro-environment and increase tumor cell ceramide levels, thus facilitating ENT1 dimerization and functionality.  This novel approach enhances nucleoside and 5FU intratumor concentrations by a factor 3x and reduces their systemic levels by more than half. The Company is progressing its lead program in aggressively advancing and metastatic Sarcoma.

Angis Bio

Angis Bio is a New Jersey biotechnology startup company focused on developing therapeutics for oncology, inflammation and infectious diseases. They have developed a new generation of precision small format therapeutics derived from the company’s unique drug discovery platforms. These platforms are based on a suite of integrated technology modules using naturally occurring templates or rationally designed constructions.

Anthroium Inc.

anthroium.com

Anthroium is a start-up R&D Services company that will create the first mechanistic virtual human model. The approach develops a virtual human modeling platform to improve drug development decisions The computational biology approach will help biopharma customers accelerate drug discovery.

Beautech Inc.
beautech.aero

Beautech Inc. is  focused on resolving issues in the personal care and flavor/fragrance industries.  The company is creating an alternative cosmetic filler ingredient that doesn’t include microplastics. 

Celleqore
celleqore.com

Celleqore, we know expertise and close collaboration are required to effectively conduct outsourced experiments, particularly in flow cytometry and cell-based assays. We are a small business with more than 50 years of experience in the pharmaceutical, biotechnology, and manufacturing industries. Our commitment and dedication to advancing scientific innovation is unmatched and driven by our passion to improve human health.

Chrom-Matrix Inc.
chrom-matrix.com

Chrom-Matrix Inc. is an innovative chromatographic company primarily focused on the creation, development, manufacturing and supply of HPLC columns, sample preparation consumables, discovery methodology with outstanding performance for separation, analysis and purification of organic chemicals and biochemicals.

Couragene
Couragene.com

Couragene is leveraging its breakthrough delivery platforms to develop next-generation gene and biologic therapies. Couragene harnesses its innovative technologies to create novel therapeutics via non-viral delivery of genome editing machinery, DNA/RNA, and other biologics. Furthermore, Couragene has discovered and developed proprietary materials for oral delivery of therapeutic agents.

Delve Therapeutics
delvetx.com

Delve Therapeutics is a discovery-stage startup researching novel oncolytic viruses.   

Enquyst Technologie
enquyst.com

Enquyst Technologies is an engineering next-generation purification technologies which will disrupt the way biological drugs are developed.

Euprovita BioLabs

EuProvita is a research reagent and R&D services company with a primary objective to develop a portfolio of recombinant human proteins specifically optimized for use in 3D cell culture models and to establish strategic partnerships with leading pharmaceutical companies and academic research laboratories.

Evivue Technologies

Evivue Technologies has a differentiated and proprietary drug delivery technology platform and will create a pipeline of 505b2 FDA approved, topically applied products for hair loss.

Linus Biotechnology Inc.
linusbio.com

LinusBio is a patient-centric, precision exposome medicine company. Originating from the world’s leading exposome laboratory at Mount Sinai Health System, Linus has developed a technology platform that builds on breakthroughs in exposome sequencing by trailblazing researchers Drs. Manish Arora, Christine Austin and Paul Curtin. The Company’s program pipeline comprises precision exposome medicine biomarkers and target discovery across disease domains for which historically no molecular endpoints have been available in medical practice or for clinical trials, including CNS (autism spectrum disorder, amyotrophic lateral sclerosis), gastroenterology (inflammatory bowel disease), renal disease and oncology. 

Neoventech
neoventech.com

Neoventech strives to be the recognized leader in topical drug and active cosmetic product development. Our dedicated R&D team has a combined of 70+ years’ experience in drug delivery, cosmetic and topical drug product development and their successful global commercialization. The mission is to assist you to transform innovative ideas into successful cosmetics or topicalpharmaceutical products to address the dermatological disorders and unmet consumer needs in skin health. Neoventech commits to partner with industrial leaders and to find better ways to deliver the high quality products and services in a timely manner.

Notitia Biotechnologies

notitiabio.com

Notitia Biotechnologies is a biotechnology startup company with a unique R&D platform created within the Rutgers University laboratories of Dr. Liping Zhao. The platform targets the ecological restoration of healthy gut microbiome.

OLI Technologies

OLI Technologies is revolutionizing end-stage renal disease treatment. Leveraging proprietary nanotechnologies, OLI is developing intelligent wearables that emulate the natural capabilities of healthy kidneys.

PolyGone Systems
polygonesystems.com

PolyGone Systems was co-founded in 2021 by Princeton Grads and Forbes 30 Under 30 fellows Nathaniel Banks & Yidian Liu in response to the global inaction in addressing escalating microplastic contamination levels. Specifically, the duo noted that while systems exist for the collection and recycling for large plastic items, none exist for intercepting, collecting and recycling microplastics. PolyGone was formed to bridge this gap by developing and deploying critical infrastructure for microplastic interception and recovery.

Venora Pharma
Venora is precision oncology company developing small molecule therapies.